Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

Description

Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.

Conditions

Radiation Exposure, Overactive Bladder, Urge Incontinence, Urgency-frequency Syndrome

Study Overview

Study Details

Study overview

Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.

Reduction in Fluoroscopy Radiation Exposure During Lead Implantation for Sacral Neuromodulation: A Randomized Prospective Study

Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

Condition
Radiation Exposure
Intervention / Treatment

-

Contacts and Locations

Loma Linda

Loma Linda University Health, Loma Linda, California, United States, 92354

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients undergoing lead implantation for sacral neuromodulation that have overactive bladder as defined by urinary urgency, frequency, nocturia with or without urgency incontinence.
  • * neurogenic bladder, BMI \>40, or peripheral neuropathy.

Ages Eligible for Study

18 Years to 89 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Loma Linda University,

Forrest Jellison, MD, PRINCIPAL_INVESTIGATOR, Loma Linda University

Study Record Dates

2025-12